Salmeterol/Fluticasone Zentiva 25 mikrogram/125 mikrogram/dos Inhalationsspray, suspension Sweden - Swedish - Läkemedelsverket (Medical Products Agency)

salmeterol/fluticasone zentiva 25 mikrogram/125 mikrogram/dos inhalationsspray, suspension

zentiva k.s. - flutikasonpropionat; salmeterolxinafoat - inhalationsspray, suspension - 25 mikrogram/125 mikrogram/dos - salmeterolxinafoat 36,32 mikrog aktiv substans; flutikasonpropionat 125 mikrog aktiv substans

Salmeterol/Fluticasone Zentiva 25 mikrogram/250 mikrogram/dos Inhalationsspray, suspension Sweden - Swedish - Läkemedelsverket (Medical Products Agency)

salmeterol/fluticasone zentiva 25 mikrogram/250 mikrogram/dos inhalationsspray, suspension

zentiva k.s. - flutikasonpropionat; salmeterolxinafoat - inhalationsspray, suspension - 25 mikrogram/250 mikrogram/dos - salmeterolxinafoat 36,32 mikrog aktiv substans; flutikasonpropionat 250 mikrog aktiv substans

Salmeterol/Fluticasone Zentiva 25 mikrogram/50 mikrogram/dos Inhalationsspray, suspension Sweden - Swedish - Läkemedelsverket (Medical Products Agency)

salmeterol/fluticasone zentiva 25 mikrogram/50 mikrogram/dos inhalationsspray, suspension

zentiva k.s. - flutikasonpropionat; salmeterolxinafoat - inhalationsspray, suspension - 25 mikrogram/50 mikrogram/dos - salmeterolxinafoat 36,32 mikrog aktiv substans; flutikasonpropionat 50 mikrog aktiv substans

Salmeterol/Fluticasone Cipla 25 mikrogram/125 mikrogram/dos Inhalationsspray, suspension Sweden - Swedish - Läkemedelsverket (Medical Products Agency)

salmeterol/fluticasone cipla 25 mikrogram/125 mikrogram/dos inhalationsspray, suspension

cipla europe nv - flutikasonpropionat; salmeterolxinafoat - inhalationsspray, suspension - 25 mikrogram/125 mikrogram/dos - salmeterolxinafoat 36,32 mikrog aktiv substans; flutikasonpropionat 125 mikrog aktiv substans - salmeterol och flutikason

Salmeterol/Fluticasone Cipla 25 mikrogram/250 mikrogram/dos Inhalationsspray, suspension Sweden - Swedish - Läkemedelsverket (Medical Products Agency)

salmeterol/fluticasone cipla 25 mikrogram/250 mikrogram/dos inhalationsspray, suspension

cipla europe nv - flutikasonpropionat; salmeterolxinafoat - inhalationsspray, suspension - 25 mikrogram/250 mikrogram/dos - salmeterolxinafoat 36,32 mikrog aktiv substans; flutikasonpropionat 250 mikrog aktiv substans - salmeterol och flutikason

Fluticasone Cipla 125 mikrogram/dos Inhalationsspray, suspension Sweden - Swedish - Läkemedelsverket (Medical Products Agency)

fluticasone cipla 125 mikrogram/dos inhalationsspray, suspension

cipla europe nv - flutikasonpropionat - inhalationsspray, suspension - 125 mikrogram/dos - flutikasonpropionat 125 mikrog aktiv substans - flutikason

Fluticasone Cipla 250 mikrogram/dos Inhalationsspray, suspension Sweden - Swedish - Läkemedelsverket (Medical Products Agency)

fluticasone cipla 250 mikrogram/dos inhalationsspray, suspension

cipla europe nv - flutikasonpropionat - inhalationsspray, suspension - 250 mikrogram/dos - flutikasonpropionat 250 mikrog aktiv substans - flutikason

Salmeterol/Fluticasone Abacus Medicine 25 mikrogram/125 mikrogram/dos Inhalationsspray, suspension Sweden - Swedish - Läkemedelsverket (Medical Products Agency)

salmeterol/fluticasone abacus medicine 25 mikrogram/125 mikrogram/dos inhalationsspray, suspension

abacus medicine a/s - flutikasonpropionat; salmeterolxinafoat - inhalationsspray, suspension - 25 mikrogram/125 mikrogram/dos - flutikasonpropionat 125 mikrog aktiv substans; salmeterolxinafoat 36,32 mikrog aktiv substans

Salmeterol/Fluticasone Abacus Medicine 25 mikrogram/250 mikrogram/dos Inhalationsspray, suspension Sweden - Swedish - Läkemedelsverket (Medical Products Agency)

salmeterol/fluticasone abacus medicine 25 mikrogram/250 mikrogram/dos inhalationsspray, suspension

abacus medicine a/s - flutikasonpropionat; salmeterolxinafoat - inhalationsspray, suspension - 25 mikrogram/250 mikrogram/dos - salmeterolxinafoat 36,32 mikrog aktiv substans; flutikasonpropionat 250 mikrog aktiv substans

Seffalair Spiromax European Union - Swedish - EMA (European Medicines Agency)

seffalair spiromax

teva b.v. - fluticasone propionate, salmeterol xinafoate - astma - läkemedel mot obstruktiv lungsjukdom, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.